(2001; 96 pages) [French] [Spanish]
Ensuring stable and adequate financing for health care is becoming increasingly difficult as a result of the combined effects of economic pressures, continued population growth and the growing burden of disease. Health care resources are stretched by the demographic shift to older populations, with more costly chronic diseases, the emergence of new diseases such as AIDS, and the resurgence of older diseases, such as tuberculosis and malaria, which need increasingly costly drugs because of growing resistance to the earlier drugs.
Market-oriented “Laissez-faire” policies are not geared to protecting the needs of the poorest people, and without government involvement the poor may be denied access to drugs. Ensuring access to essential drugs, particularly in remote areas, can be a major challenge to those involved in developing and implementing drug policy.